Uncategorized
Valeant’s CFO to step down once successor is appointed
Valeant Pharmaceuticals International has announced Howard B. Schiller advised the company he plans to step down as chief financial officer upon the appointment of a successor.Schiller will remain as chief financial officer (CFO) during the search for a successor, according to a company press release release. He also intends to stay on Valeant’s board of directors and will stand for re-election in that position at the annual stockholder meeting in May, the release stated.